Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin in Gastro-Esophageal Reflux Disease
NCT00915616Phase 3Withdrawn
- Sponsor
- Mansoura University
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of melatonin in gastroesophageal reflux disease (GERD), sponsored by Mansoura University. Status: withdrawn.
02
Drugs
melatonin
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00915616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00915616.